Access criteria for anti-TNF agents in spondyloarthritis: influence on comparative 1-year cost-effectiveness estimates

Stephanie Harvard 1 Daphne Guh 2 Nick Bansback 1 Pascal Richette 3 Alain Saraux 4, 5 Bruno Fautrel 6 Aslam Anis 7
1 UPMC - Université Pierre et Marie Curie - Paris 6
2 Centre for Health Evaluation and Outcome Sciences
3 Centre Viggo-Petersen, service de rhumatologie
4 LBAI - Lymphocyte B et Auto-immunité
5 CIC Brest
6 UPMC - Université Pierre et Marie Curie - Paris 6 - UFR de Médecine Pierre et Marie Curie
7 UBC - University of British Columbia
Document type :
Journal articles
Complete list of metadatas
https://hal.univ-brest.fr/hal-02048666
Contributor : Ghislaine Calvez <>
Submitted on : Monday, February 25, 2019 - 4:30:52 PM
Last modification on : Tuesday, April 2, 2019 - 2:00:43 AM

Identifiers

  • HAL Id : hal-02048666, version 1

Collections

UNIV-BREST | UPMC | IMMUNO | IBSAM | SORBONNE-UNIVERSITE

Citation

Stephanie Harvard, Daphne Guh, Nick Bansback, Pascal Richette, Alain Saraux, et al.. Access criteria for anti-TNF agents in spondyloarthritis: influence on comparative 1-year cost-effectiveness estimates. Cost Effectiveness and Resource Allocation, BioMed Central, 2017, 15 (1). ⟨hal-02048666⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

45

Contact

Informations

CCSD